A Aforeworn
Forewarned is forearmed.
Home › Niches › Pharmacy & Controlled Substances › Change
Low urgency

DEA Releases Fourth Temporary Extension of Telemedicine Flexibilities - RCPA | PA

Detected July 16, 2026 · in Pharmacy & Controlled Substances

DEA extends telemedicine flexibilities for controlled substance prescribing through December 31, 2025, maintaining the current waiver of in-person exam requirement.

Aforeworn detected this change in the Pharmacy & Controlled Substances space on July 16, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Independent pharmacies, retail chains, compounding pharmacies, long-term-care pharmacies should confirm how it applies to their specific situation before acting. There is a time constraint attached: December 31, 2025. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

The DEA has issued a fourth temporary extension of telemedicine flexibilities, allowing practitioners to prescribe controlled substances via telemedicine without an initial in-person exam until December 31, 2025.

Who it affects

Independent pharmacies, retail chains, compounding pharmacies, long-term-care pharmacies

What you must do

No immediate action required; continue operating under existing telemedicine prescribing protocols.

Deadline

December 31, 2025

Source: https://news.google.com/rss/articles/CBMingFBVV95cUxQN2dUTEpuOS1SM3R3al9kTGVxaXBBX3FzYWVBcDI1dmZJaWVONVhDM3FLb0U3ZnZfV1AwN1YtR3dPTjZZWDRpYV9pMEdhUjNJZktWMFREMnVpOGtNZHJIMGxCbmNXeHFoSVVReTEwZTY2eFpYSzJTM2VDVDgtd0NqVWhNbWV0R0VBSnRhTWFiYlRFMWdueFYtV1ZYbmxudw?oc=5

Never miss a change like this again

Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Pharmacy & Controlled Substances